ATG7 and metabolic dysfunction-associated steatotic liver disease: GSEA analysis showed significant enrichment of the Atg7-KO gene signature in NAFLD samples that were comprised primarily of samples from advanced NAFLD (F3 or F4), along with enrichment for YAP target genes (Fig. 6a).